Results 21 to 30 of about 821,037 (255)

The air we breathe: understanding the impact of the environment on pneumonia

Pneumonia, 2022
An increased risk of community-acquired pneumonia has been shown in residents of rural livestock farming areas in the Netherlands and United States, probably due to air pollution exposure or zoonotic infections.
Lidwien A. M. Smit
doaj   +1 more source

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population

Pneumonia, 2020
Background Childhood pneumonia continues to be a disease that causes severe morbidity and mortality among children mainly in South-East Asia and Africa though it is not so in the developed world. Pneumonia accounts for 16% of all deaths of children under
Sanath Thushara Kudagammana, Ruchira Ruwanthika Karunaratne, Thilini Surenika Munasinghe, Haputhanthirige Donna Wasana Samankumari Kudagammana   +3 more
doaj   +1 more source

Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya. [PDF]

, 2013
Severe lower respiratory tract infection (LRTI) in infants caused by respiratory syncytial virus (RSV) has been associated with later pneumonia hospitalization among children.
Eric O. Ohuma, Nokes, D. James, Nokes, DJ, Ngama, Mwanajuma, Ngama, M, Patrick Kiio Munywoki, Bauni, E, Scott, J Anthony G, Ohuma, Eric O., Munywoki, Patrick Kiio, Scott, John, Ohuma, EO, J. Anthony G. Scott, Munywoki, PK, Bauni, Evasius, Mwanajuma Ngama, Scott, J. Anthony G., Nokes, D James, Ohuma, Eric O, Evasius Bauni, D. James Nokes   +20 more
core   +1 more source

The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England

Pneumonia, 2019
Background UK specific data on the risk of developing hospitalised CAP for patients with underlying comorbidities is lacking. This study compared the likelihood of hospitalised all-cause community acquired pneumonia (CAP) in patients with certain high ...
J. Campling, D. Jones, J. D. Chalmers, Q. Jiang, A. Vyse, H. Madhava, G. Ellsbury, M. Slack   +7 more
doaj   +1 more source

The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniae

Pneumonia, 2021
Polyamines are common intracellular metabolites of nearly all cells, and their conservation across a vast diversity of cells suggests critical roles for these compounds in cellular physiology.
Bindu Nanduri, Edwin Swiatlo
doaj   +1 more source

Atypical bacterial pneumonia in the HIV-infected population

Pneumonia, 2017
Human immunodeficiency virus (HIV)-infected individuals are more susceptible to respiratory tract infections by other infectious agents (viruses, bacteria, parasites, and fungi) as their disease progresses to acquired immunodeficiency syndrome.
Breanne M. Head, Adriana Trajtman, Zulma V. Rueda, Lázaro Vélez, Yoav Keynan   +4 more
doaj   +1 more source

Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study

Pneumonia, 2023
Background Respiratory pathogens, including SARS-CoV-2, can cause pulmonary structural damage and physiologic impairment, which may increase the risk of subsequent lower respiratory tract infections (LRTI).
Katia J. Bruxvoort, Heidi Fischer, Joseph A. Lewnard, Vennis X. Hong, Magdalena Pomichowski, Lindsay R. Grant, Luis Jódar, Bradford D. Gessner, Sara Y. Tartof   +8 more
doaj   +1 more source

Decreased serum level of thioredoxin 1 in female patients with pneumonia and its combinational use with haptoglobin for the specific diagnoses of pneumonia and lung cancer

Pneumonia, 2015
Thioredoxin 1 (Trx1) and haptoglobin (Hp) are known to be involved in pathophysiology. This study was conducted to evaluate their diagnostic significance.
Mee-Kyung Cha, Il-Han Kim
doaj   +1 more source

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke   +4 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source